Genomics Personalized Health Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066395
  • May 2021
  • Biotechnology
  • 142 Pages
The Genomics Personalized Health Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered QIAGEN, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Lonza, Invitae Corporation, Genetic Technologies Limited, Eastern Biotech, DNA Genotek Inc. (OraSure Technologies, Inc.)
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Genomics Personalized Health market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Genomics Personalized Health market is expected to attain Pre COVID-19 levels by mid-2022.

Genomics Personalized Health Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Genomics Personalized Health market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Genomics Personalized Health Market Competitive and Premeditated Analysis
In the Genomics Personalized Health report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Genomics Personalized Health research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Genomics Personalized Health Market:
The Genomics Personalized Health market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. QIAGEN, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Lonza, Invitae Corporation, Genetic Technologies Limited, Eastern Biotech, DNA Genotek Inc. (OraSure Technologies, Inc.)

The Genomics Personalized Health market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Genomics Personalized Health Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Genomics Personalized Health market:
By Technology
NGS platforms
RT-PCR
Microarray
Genetic Analyzers
Test Type
Oncology Testing
Infectious Disease Testing
Orphan Disease Testing
Autoimmune Disease Testing
Obstetrics Testing
Others
End User
Academics & Research Institutes
Diagnostic Centers
Others

Regional Analysis of the Genomics Personalized Health market:
The Genomics Personalized Health market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Genomics Personalized Health report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Genomics Personalized Health market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Genomics Personalized Health market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Genomics Personalized Health market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Genomics Personalized Health market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Genomics Personalized Health market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Genomics Personalized Health market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Genomics Personalized Health market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Genomics Personalized Health market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • QIAGEN
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • Lonza
  • Invitae Corporation
  • Genetic Technologies Limited
  • Eastern Biotech
  • DNA Genotek Inc. (OraSure Technologies, Inc.)
  • NGS platforms
  • RT-PCR
  • Microarray
  • Genetic Analyzers
  • Academics & Research Institutes
  • Diagnostic Centers
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Genomics Personalized Health Market Snapshot
          2.1.1. Global Genomics Personalized Health Market By Technology,2019
               2.1.1.1.NGS platforms
               2.1.1.2.RT-PCR
               2.1.1.3.Microarray
               2.1.1.4.Genetic Analyzers
          2.1.2. Global Genomics Personalized Health Market By End User,2019
               2.1.2.1.Academics & Research Institutes
               2.1.2.2.Diagnostic Centers
               2.1.2.3.Others
          2.1.3. Global Genomics Personalized Health Market By End-use,2019
          2.1.4. Global Genomics Personalized Health Market By Geography,2019

3. Global Genomics Personalized Health Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028

5. Global Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028

6. Global Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028

7. Global Genomics Personalized Health Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Genomics Personalized Health Market Analysis, 2018 – 2028 
          7.2.1. North America Genomics Personalized Health Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Genomics Personalized Health Market Analysis, 2018 – 2028 
          7.3.1.  Europe Genomics Personalized Health Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Genomics Personalized Health Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Genomics Personalized Health Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Genomics Personalized Health Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Genomics Personalized Health Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Genomics Personalized Health Market Analysis, 2018 – 2028 
          7.6.1.  MEA Genomics Personalized Health Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Genomics Personalized Health Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Genomics Personalized Health Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Genomics Personalized Health Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Genomics Personalized Health Providers
        8.4.1 QIAGEN
                8.4.1.1 Business Description
                8.4.1.2 QIAGEN Geographic Operations
                8.4.1.3 QIAGEN Financial Information
                8.4.1.4 QIAGEN Product Positions/Portfolio
                8.4.1.5 QIAGEN Key Developments
        8.4.2 Illumina, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Illumina, Inc. Geographic Operations
                8.4.2.3 Illumina, Inc. Financial Information
                8.4.2.4 Illumina, Inc. Product Positions/Portfolio
                8.4.2.5 Illumina, Inc. Key Developments
        8.4.3 Thermo Fisher Scientific, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Thermo Fisher Scientific, Inc. Geographic Operations
                8.4.3.3 Thermo Fisher Scientific, Inc. Financial Information
                8.4.3.4 Thermo Fisher Scientific, Inc. Product Positions/Portfolio
                8.4.3.5 Thermo Fisher Scientific, Inc. Key Developments
        8.4.4 Bio-Rad Laboratories, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Bio-Rad Laboratories, Inc. Geographic Operations
                8.4.4.3 Bio-Rad Laboratories, Inc. Financial Information
                8.4.4.4 Bio-Rad Laboratories, Inc. Product Positions/Portfolio
                8.4.4.5 Bio-Rad Laboratories, Inc. Key Developments
        8.4.5 F. Hoffmann-La Roche Ltd
                8.4.5.1 Business Description
                8.4.5.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.5.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.5.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.5.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.6 Lonza
                8.4.6.1 Business Description
                8.4.6.2 Lonza Geographic Operations
                8.4.6.3 Lonza Financial Information
                8.4.6.4 Lonza Product Positions/Portfolio
                8.4.6.5 Lonza Key Developments
        8.4.7 Invitae Corporation
                8.4.7.1 Business Description
                8.4.7.2 Invitae Corporation Geographic Operations
                8.4.7.3 Invitae Corporation Financial Information
                8.4.7.4 Invitae Corporation Product Positions/Portfolio
                8.4.7.5 Invitae Corporation Key Developments
        8.4.8 Genetic Technologies Limited
                8.4.8.1 Business Description
                8.4.8.2 Genetic Technologies Limited Geographic Operations
                8.4.8.3 Genetic Technologies Limited Financial Information
                8.4.8.4 Genetic Technologies Limited Product Positions/Portfolio
                8.4.8.5 Genetic Technologies Limited Key Developments
        8.4.9 Eastern Biotech
                8.4.9.1 Business Description
                8.4.9.2 Eastern Biotech Geographic Operations
                8.4.9.3 Eastern Biotech Financial Information
                8.4.9.4 Eastern Biotech Product Positions/Portfolio
                8.4.9.5 Eastern Biotech Key Developments
        8.4.10 DNA Genotek Inc. (OraSure Technologies, Inc.)
                8.4.10.1 Business Description
                8.4.10.2 DNA Genotek Inc. (OraSure Technologies, Inc.) Geographic Operations
                8.4.10.3 DNA Genotek Inc. (OraSure Technologies, Inc.) Financial Information
                8.4.10.4 DNA Genotek Inc. (OraSure Technologies, Inc.) Product Positions/Portfolio
                8.4.10.5 DNA Genotek Inc. (OraSure Technologies, Inc.) Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Genomics Personalized Health Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Genomics Personalized Health Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Genomics Personalized Health Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Genomics Personalized Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Genomics Personalized Health Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Genomics Personalized Health Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Genomics Personalized Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Genomics Personalized Health Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Genomics Personalized Health Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Genomics Personalized Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Genomics Personalized Health Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Genomics Personalized Health Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Genomics Personalized Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Genomics Personalized Health Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Genomics Personalized Health Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Genomics Personalized Health Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Genomics Personalized Health: Market Segmentation 
FIG. 2 Global Genomics Personalized Health Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Genomics Personalized Health Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Genomics Personalized Health Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Genomics Personalized Health Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Genomics Personalized Health Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Genomics Personalized Health Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Genomics Personalized Health Providers, 2019
FIG. 11 Global Genomics Personalized Health Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Genomics Personalized Health Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Genomics Personalized Health Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Genomics Personalized Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Genomics Personalized Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Genomics Personalized Health Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Genomics Personalized Health Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Genomics Personalized Health Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Genomics Personalized Health market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Genomics Personalized Health Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Genomics Personalized Health Market Value, By Segment1, 2018 – 2028
TABLE  North America Genomics Personalized Health Market Value, By Segment2, 2018 – 2028
TABLE  North America Genomics Personalized Health Market Value, By Country, 2018 – 2028
TABLE  Europe Genomics Personalized Health Market Value, By Segment1, 2018 – 2028
TABLE  Europe Genomics Personalized Health Market Value, By Segment2, 2018 – 2028
TABLE  Europe Genomics Personalized Health Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Genomics Personalized Health Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Genomics Personalized Health Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Genomics Personalized Health Market Value, By Country, 2018 – 2028
TABLE  Latin America Genomics Personalized Health Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Genomics Personalized Health Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Genomics Personalized Health Market Value, By Country, 2018 – 2028
TABLE  MEA Genomics Personalized Health Market Value, By Segment1, 2018 – 2028
TABLE  MEA Genomics Personalized Health Market Value, By Segment2, 2018 – 2028
TABLE  MEA Genomics Personalized Health Market Value, By Country, 2018 – 2028
TABLE  QIAGEN: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Illumina, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lonza: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Invitae Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genetic Technologies Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eastern Biotech: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  DNA Genotek Inc. (OraSure Technologies, Inc.): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Genomics Personalized Health Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Genomics Personalized Health Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Genomics Personalized Health Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Genomics Personalized Health Market, By Geography, 2019 (US$ Mn)
FIG.  Global Genomics Personalized Health Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Genomics Personalized Health Providers, 2016
FIG.  Global Genomics Personalized Health Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global RT-PCR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Microarray Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genetic Analyzers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Genomics Personalized Health Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Diagnostic Centers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Genomics Personalized Health Market Value, 2018 – 2028, (US$ Mn)